{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-22-010697","form_type":"8-K","ticker":"VTGN","cik":"0001411685","company_name":"Vistagen Therapeutics, Inc.","filed_at":"2022-05-03T23:59:59+00:00","discovered_at":"2026-05-14T18:04:00.579268+00:00","generated_at":"2026-06-26T01:22:40.072221+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"VistaGen appoints Reid Adler as Chief Legal Officer effective May 2, 2022","bullets":["Reid G. Adler appointed CLO; will oversee legal affairs and provide strategic guidance to Executive Team and Board.","Adler previously founded Capital Technology Law Group and had represented VistaGen as outside counsel.","Career includes partner at Morrison & Foerster and Morgan Lewis, general counsel at J. Craig Venter Institute.","Adler was founding director of NIH Office of Technology Transfer, building a team of over 40 people.","Company paid Capital Technology Law Group $210,000 in FY ended March 2022 and $18,000 in April 2022 for legal services."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-22-010697","json":"https://secwatch.observer/filing/0001437749-22-010697.json","markdown":"https://secwatch.observer/filing/0001437749-22-010697.md","text":"https://secwatch.observer/filing/0001437749-22-010697.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1411685/000143774922010697/0001437749-22-010697-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1411685/000143774922010697/vtgn20220502_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T01:22:40.072221+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"63c5c11ebe","claim":"Reid G. Adler was appointed as Chief Legal Officer at Vistagen Therapeutics, Inc..","evidence_excerpt":"On May 2, 2022, the Board of Directors (the “ Board ”) of VistaGen Therapeutics, Inc. (the “ Company ”), appointed Mr. Reid G. Adler, age 67, as the Company’s Chief Legal Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1411685/000143774922010697/0001437749-22-010697-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Legal Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}